Rigel Pharmaceuticals, Inc. (RIGL) ownership: Top institutional holder: BlackRock, Inc. ($47.83M). Insider activity: Net Seller (5 buys, 15 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 1768907.00 | $47.83M | 2026-03-31 |
| VANGUARD GROUP INC | 1038408.00 | $44.48M | 2025-12-31 |
| ARMISTICE CAPITAL, LLC | 1280000.00 | $34.61M | 2026-03-31 |
| STATE STREET CORP | 1120238.00 | $30.29M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 764193.00 | $20.66M | 2026-03-31 |
| ACADIAN ASSET MANAGEMENT LLC | 666426.00 | $18.01M | 2026-03-31 |
| LSV ASSET MANAGEMENT | 601507.00 | $16.27M | 2026-03-31 |
| MARSHALL WACE, LLP | 598378.00 | $16.18M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-06-01 | |
| Buy | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Buy | null | 2026-06-01 | |
| Buy | null | 2026-06-01 | |
| Sell | null | 2026-06-01 | |
| Sell | null | 2026-06-01 |
Back to RIGL overview · RIGL earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.